Besides, monoclonal therapies such as Panitumumab and Cetuximab [monoclonal antibodies directed to the epidermal growth factor receptor (EGFR)] have demonstrated clinical efficacy in patients with colorectal cancer in advanced stages. This evidence concerns the gene EGFR and colorectal cancer.